Physician profile
Kelsey Baker
NPI 1346803889
$239.10
in general payments reported to CMS, 2019-2025
10 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.15 · 2024: $77.65 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $41.52 | 2024 | Veozah |
| Boston Scientific Corporation | $36.34 | 2025 | Wavewriter Alpha Prime 16 |
| Exeltis, USA INC. | $35.35 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $25.08 | 2025 | Fluent Fluid Management System |
| Exact Sciences Corporation | $21.77 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $21.57 | 2025 | |
| Myriad Women'S Health, INC. | $15.15 | 2023 | Myrisk |
| Gynesonics, INC. | $14.36 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $13.98 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $13.98 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.